These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9812725)

  • 41. Medication abortion.
    Bartz D; Goldberg A
    Clin Obstet Gynecol; 2009 Jun; 52(2):140-50. PubMed ID: 19407520
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vascular endothelial growth factor mRNA and its protein expression in decidua after terminating early pregnancy by mifepristone plus misoprostol.
    Huang L; Shi Y
    Chin Med J (Engl); 2001 May; 114(5):517-9. PubMed ID: 11780417
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium.
    Papp C; Schatz F; Krikun G; Hausknecht V; Lockwood CJ
    Early Pregnancy (Cherry Hill); 2000 Oct; 4(4):230-9. PubMed ID: 11742418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomized, double-blind, controlled trial of mifepristone in capsule versus tablet form followed by misoprostol for early medical abortion.
    Liao AH; Han XJ; Wu SY; Xiao DZh; Xiong CL; Wu XR
    Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):211-6. PubMed ID: 15358467
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mifepristone in second-trimester medical abortion: a randomized controlled trial.
    Kapp N; Borgatta L; Stubblefield P; Vragovic O; Moreno N
    Obstet Gynecol; 2007 Dec; 110(6):1304-10. PubMed ID: 18055725
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Are two doses of misoprostol after mifepristone for early abortion better than one?
    Coyaji K; Krishna U; Ambardekar S; Bracken H; Raote V; Mandlekar A; Winikoff B
    BJOG; 2007 Mar; 114(3):271-8. PubMed ID: 17217359
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Early termination of pregnancy with pharmacological means].
    Honkanen H; von Hertzen H
    Duodecim; 2000; 116(12):1277-82; quiz 1283, 1308. PubMed ID: 11988962
    [No Abstract]   [Full Text] [Related]  

  • 48. Current medical abortion care.
    Creinin MD
    Curr Womens Health Rep; 2003 Dec; 3(6):461-9. PubMed ID: 14613667
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effects of mifepristone on proliferation and apoptosis in early chorionic villi].
    Yang Y; Cao Z; Han Z
    Zhonghua Fu Chan Ke Za Zhi; 1998 May; 33(5):268-70. PubMed ID: 10682435
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Termination of 10-16 weeks's gestation with mifepristone plus misoprostol: a multicentre randomized clinical trial].
    Cheng L
    Zhonghua Fu Chan Ke Za Zhi; 1999 May; 34(5):268-71. PubMed ID: 11326930
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effects of mifepristone on expression of estrogen receptor and progesterone receptor in cultured human eutopic and ectopic endometria].
    Jiang J; Wu R; Wang Z
    Zhonghua Fu Chan Ke Za Zhi; 2001 Apr; 36(4):218-21. PubMed ID: 11783365
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential regulation of colony stimulating factor 1 and macrophage migration inhibitory factor expression by inflammatory cytokines in term human decidua: implications for macrophage trafficking at the fetal-maternal interface.
    Arcuri F; Buchwalder L; Toti P; Cintorino M; Tosi P; Lockwood CJ; Rybalov B; Schatz F
    Biol Reprod; 2007 Mar; 76(3):433-9. PubMed ID: 17108334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13-22 weeks gestation.
    Fiala C; Swahn ML; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2005 Nov; 20(11):3072-7. PubMed ID: 16055455
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Embryotoxicity and teratogenicity of DL111-IT, an early pregnancy-terminating agent, in the subsequent gestation following administration in rats.
    Zhou HJ; Fang RY; Yang BZ; Zhang YP
    Contraception; 1991 Mar; 43(3):287-93. PubMed ID: 2036798
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effects of artesunate on progestrone estrogen content and decidua in rats].
    Lou XE; Zhou HJ
    Yao Xue Xue Bao; 2001 Apr; 36(4):254-7. PubMed ID: 12580051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Initial Dutch experiences with early pregnancy interruption using the antiprogesterone agent mifepriston].
    Vervest HA; Haspels AA
    Ned Tijdschr Geneeskd; 1985 Aug; 129(35):1680-3. PubMed ID: 4047227
    [No Abstract]   [Full Text] [Related]  

  • 57. Roles of Mifepristone on the Regulation of Cytotoxic Lymphocytes and Regulatory T Cells.
    Liu L; Zhou F; Qin J; Qian Z; Huang L
    Gynecol Obstet Invest; 2017; 82(6):533-537. PubMed ID: 29080885
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Leukocyte populations and steroid receptor expression in human first-trimester decidua; regulation by antiprogestin and prostaglandin E analog.
    Milne SA; Henderson TA; Kelly RW; Saunders PT; Baird DT; Critchley HO
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4315-21. PubMed ID: 15814773
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Signal transducer and activator of transcription 3 is expressed in the decidualized mesometrium of pregnancy and associates with the progesterone receptor through protein-protein interactions.
    Liu T; Ogle TF
    Biol Reprod; 2002 Jul; 67(1):114-8. PubMed ID: 12080006
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potentiating effect of epostane on pregnancy terminating activity of RU 486 in the rat.
    Vanage G; Kadam PA; Bardin CW; Koide SS
    Contraception; 1993 May; 47(5):499-506. PubMed ID: 8513677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.